Literature DB >> 20428729

WHOQOL-OLD assessment of quality of life in elderly patients with Parkinson's disease: influence of sleep and depressive symptoms.

Regina Margis1, Karina Carvalho Donis, Suzana Veiga Schönwald, Carlos R M Rieder.   

Abstract

OBJECTIVE: Parkinson's disease is a neurodegenerative disease with a number of motor and non-motor features that can affect quality of life. In this study, we aimed to assess quality of life, as well as to evaluate the potential determinants of quality of life, such as sleep quality, motor and depressive symptoms, in elderly patients with Parkinson's disease.
METHOD: This was a cross-sectional study in which we applied the World Health Organization Quality of Life Assessment for Older Adults in 57 Parkinson's disease patients over 60 years of age.
RESULTS: Total World Health Organization Quality of Life Assessment for Older Adults score was found to be associated with Parkinson's disease severity (rs = -0.43; p < 0.001). World Health Organization Quality of Life Assessment for Older Adults scores for sensory abilities (facet 1) and social participation (facet 4) were higher among the patients with mild Parkinson's disease than among those in the more advanced stages (rs = -0.43; p < 0.001). Facet 1 scores were found to be associated with Pittsburgh Sleep Quality Index and Parkinson's Disease Sleep Scale score (rp = -0.46 and rp = 0.41; p < 0.001, respectively). The Geriatric Depression Scale score showed an association with the total score on the World Health Organization Quality of Life Assessment for Older Adults (rp = -0.70; p < 0.001)
CONCLUSION: Quality of life in Parkinson's disease patients can be assessed by the World Health Organization Quality of Life Assessment for Older Adults. Greater Parkinson's disease severity can worsen patient quality of life, as can the presence of depressive symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 20428729     DOI: 10.1590/s1516-44462010005000008

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  5 in total

1.  Behavioral impairments and serotonin reductions in rats after chronic L-dopa.

Authors:  Branden J Stansley; Bryan K Yamamoto
Journal:  Psychopharmacology (Berl)       Date:  2015-06-03       Impact factor: 4.530

2.  Evaluation of quality of life in patients with obstructive sleep apnea.

Authors:  Alimohamad Asghari; Fatemeh Mohammadi; Seyed Kamran Kamrava; Maryam Jalessi; Mohammad Farhadi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-19       Impact factor: 2.503

3.  Neuropsychological profile of Parkinson's disease patients selected for deep brain stimulation surgery.

Authors:  Flavia Amaral Machado; Carlos Roberto Rieder; Arlete Hilbig; Caroline Tozzi Reppold
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec

4.  Sleep disturbances and depression severity in patients with Parkinson's disease.

Authors:  Daniel B Kay; Jared J Tanner; Dawn Bowers
Journal:  Brain Behav       Date:  2018-04-23       Impact factor: 2.708

5.  Association between Agility, Health-Related Quality of Life, Depression, and Anthropometric Variables in Physically Active Older Adult Women with Depression.

Authors:  Carmen Galán-Arroyo; Damián Pereira-Payo; Miguel A Hernández-Mocholí; Eugenio Merellano-Navarro; Jorge Pérez-Gómez; Jorge Rojo-Ramos; José Carmelo Adsuar
Journal:  Healthcare (Basel)       Date:  2022-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.